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ABSTRACT
Background: Associations between increased dietary fat and decreased carbohydrate intake with circulating HDL and
non-HDL cholesterol have not been conclusively determined.
Objective: We assessed these relations in 8 European observational human studies participating in the European
Nutritional Phenotype Assessment and Data Sharing Initiative (ENPADASI) using harmonized data.
Methods: Dietary macronutrient intake was recorded using study-specific dietary assessment tools. Main outcome
measures were lipoprotein cholesterol concentrations: HDL cholesterol (mg/dL) and non-HDL cholesterol (mg/dL). A
cross-sectional analysis on 5919 participants (54% female) aged 13–80 y was undertaken using the statistical platform
DataSHIELD that allows remote/federated nondisclosive analysis of individual-level data. Generalized linear models
(GLM) were fitted to assess associations between replacing 5% of energy from carbohydrates with equivalent energy
from total fats, SFAs, MUFAs, or PUFAs with circulating HDL cholesterol and non-HDL cholesterol. GLM were adjusted
for study source, age, sex, smoking status, alcohol intake and BMI.
Results: The replacement of 5% of energy from carbohydrates with total fats or MUFAs was statistically significantly
associated with 0.67 mg/dL (95% CI: 0.40, 0.94) or 0.99 mg/dL (95% CI: 0.37, 1.60) higher HDL cholesterol, respectively,
but not with non-HDL cholesterol concentrations. The replacement of 5% of energy from carbohydrates with SFAs or
C© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition. All rights reserved. For permissions, please e-mail:
journals.permissions@oup.com
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PUFAs was not associated with HDL cholesterol, but SFAs were statistically significantly associated with 1.94 mg/dL
(95% CI: 0.08, 3.79) higher non-HDL cholesterol, and PUFAs with –3.91 mg/dL (95% CI: –6.98, –0.84) lower non-HDL
cholesterol concentrations. A statistically significant interaction by sex for the association of replacing carbohydrates
with MUFAs and non-HDL cholesterol was observed, showing a statistically significant inverse association in males and
no statistically significant association in females. We observed no statistically significant interaction by age.
Conclusions: The replacement of dietary carbohydrates with fats had favorable effects on lipoprotein cholesterol
concentrations in European adolescents and adults when fats were consumed as MUFAs or PUFAs but not as SFAs. J
Nutr 2021;00:1–13.
Keywords: energy density models, substitution, blood lipids, dietary intake, fatty acids, carbohydrates, adults,
adolescents, data sharing, data integration
Introduction
Cardiovascular diseases (CVDs) are the most common cause
of death worldwide, causing over 4 million deaths (45%
of all deaths) each year across Europe (1). Key risk factors
accounting for ∼50% of CVDs are alterations in the lipoprotein
metabolism such as high concentrations of total (TC) and LDL
cholesterol, and low concentrations of HDL cholesterol (2).
Non-HDL cholesterol reflects the full burden of cholesterol
carried by all potentially atherogenic particles, including
LDL cholesterol, intermediate density lipoproteins, VLDLs,
and remnant lipoproteins (3). European guidelines recommend
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a reduction of TC and LDL cholesterol concentrations as
primary targets in therapeutic interventions for both primary
and secondary prevention of CVD (4). However, several
meta-analyses found that non-HDL cholesterol correlated
more closely with cardiovascular risk than LDL cholesterol,
and non-HDL cholesterol has therefore recently emerged
as a new target for the prevention of cardiovascular events
(5). Non-HDL cholesterol is considered a better parameter
because it includes remnant cholesterol and is independent of
triglyceride variability (6). In addition, indirect measurement
of LDL cholesterol using the traditional Friedewald equation,
as is common in clinical practice, tends to underestimate
LDL cholesterol concentrations (7), particularly in those with
lower LDL cholesterol (<70 mg/dL) and higher triglyceride
concentrations (≥150 mg/dL) (8).
It has been estimated that diet-related risks accounted for
2.1 million deaths from CVDs (95% uncertainty interval [UI],
1.7–2.5 million) in the WHO European Region within 1 y in
2016, reflecting 22.4% of all deaths and 49.2% of CVD deaths
(9). Modifying the macronutrient composition of habitual diet
can have beneficial effects on lowering CVD risk via lipid risk
factors (10). For example, diets low in SFAs are recommended
for the prevention of CVD by lowering LDL cholesterol
concentrations (11), whereas diets rich in carbohydrates have
shown detrimental effects on blood lipids by reducing HDL
cholesterol concentrations and raising fasting concentrations
of triglycerides (12, 13). There is a need to better understand
the effects of replacing carbohydrates with different types of
fats in relation to lipoprotein profiles, especially in relation
to non-HDL cholesterol. In randomized dietary intervention
trials, substituting carbohydrates with unsaturated fatty acids,
predominantly MUFAs, increased HDL cholesterol and reduced
LDL cholesterol concentrations (10, 14, 15). Moreover, the
replacement of carbohydrates with PUFAs increased HDL
cholesterol and decreased TC and LDL cholesterol concentra-
tions, whereas substituting carbohydrates with SFAs increased
TC, HDL cholesterol, and LDL cholesterol (15, 16). However,
there is little evidence on modified macronutrient composition
and non-HDL cholesterol. In addition, randomized trials often
used strictly controlled dietary interventions (14, 15), were
conducted in special study collectives (prehypertension or Stage
1 hypertension (14), overweight or obese (17)), had narrow age-
ranges and/or small sample size (14, 15) precluding sex- or age-
specific analyses and inferences to the habitual diet in the general
population.
Therefore, in the present study we investigated the asso-
ciation of the isocaloric replacement of carbohydrates with
total fat or different types of fat with blood lipoproteins
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(HDL cholesterol, non-HDL cholesterol, and the ratio of
HDL cholesterol to TC [HDL cholesterol/TC]) by sex and
age in 8 European observational studies participating in the
European Nutritional Phenotype Assessment and Data Sharing
Initiative (ENPADASI) project (18) covering a broad age range.
Harmonized datasets were analyzed in a federated way in the
ENPADASI Data Sharing Initiative for Nutrition (DASH-IN)
(www.enpadasi.eu) implementation of DataSHIELD (19, 20), a
statistical platform that allows remote/federated nondisclosive
analysis of individual-level data from multiple studies without
physically pooling or sharing them.
Methods
Study population
The observational studies included in the present study were identified
in the ENPADASI initiative where a total of 26 observational studies
were identified (18). Briefly, a consortium was built to identify studies
from consortium partners with a wealth of data and metadata,
particularly on dietary intake and traditional and omics biomarkers,
as well as to develop the DASH-IN infrastructure to facilitate data
exchange and data interpretation in order to increase the robustness
of results from future joint (pooled or federated) data analysis in
nutritional epidemiology (www.enpadasi.eu).
We planned to include studies with data on dietary macronutrient
intake and blood lipids such as TC and HDL cholesterol. From the
26 observational studies identified in ENPADASI, 10 studies fulfilled
the inclusion criteria and were therefore preselected. An invitation to
participate in the present study was sent to the principal investigators
of the preselected studies. Those who accepted the invitation (8 out
of 10) were included in our analyses. The studies included in this
federated analysis are described in Table 1. Briefly, we included 8 studies
comprising a total number of 12,983 participants from the general
population aged 13–80 y: 1 study from Belgium (Nutrition, Environ-
ment and Cardiovascular Health [NESCaV]) (21), 5 from Germany
(Bavarian Food Consumption Survey II [BVS II]) (22), ActivE (23),
EPIC (European Prospective Investigation into Cancer and Nutrition)-
Potsdam substudy (24), DOrtmund Nutritional and Anthropometric
Longitudinally Designed Study (DONALD) (25), German Infant Study
on the Influence of Nutrition Intervention plus environmental and
genetic influences on allergy development (GINIplus), and Influence of
Life-style related factors on the development of the Immune System
and Allergies in East and West Germany (LISA) (26), 1 from Italy
(Italian Network of Genetic Isolates – Friuli Venezia Giulia [INGI-
FVG]) (27), and 1 from Spain (Pizarra) (28). Three studies were cross-
sectional and 5 were longitudinal by design, in which case data at
baseline or at a single follow-up (GINIplus and LISA) were used for the
cross-sectional analysis. All of the participants of the studies provided




Dietary macronutrient intake (fat, carbohydrates, and protein intake)
was assessed using multiple 24-h dietary recalls (BVS-II [22], EPIC
substudy [24], and Pizarra [28]), self-completed, paper- or computer-
based semiquantitative FFQs (NESCaV [21], GINIplus and LISA
[29]), self-completed and paper-based food records (ActivE [23] and
DONALD [25]), or other methods, e.g. dietary history interview (INGI-
FVG) (27) (Table 1). Dietary assessment instruments were validated
and validation results have been published elsewhere (30–35), with the
exception of ActivE, in which the food record was validated against
doubly labeled water (for total energy expenditure/total energy intake,
unpublished data). From the respective dietary assessment instrument,
energy intake (kcal/d) and macronutrient intakes (total fat, SFA, MUFA,
PUFA, protein, and carbohydrate, all in g/d) were calculated using
country-specific food composition tables.
Outcome variables.
Blood lipids (HDL cholesterol and TC) were measured in plasma
samples in the EPIC substudy and in serum in all other studies
(Table 1). Non-HDL cholesterol and the ratio of HDL cholesterol to
TC (HDL cholesterol/TC) were calculated (see data harmonization
process).
Covariables.
Covariables such as age, sex, smoking status, and alcohol consumption,
were obtained from study-specific questionnaires. Height (cm) and
weight (kg) were measured in each study (Supplemental Table 1).
Data harmonization process
For the purpose of data harmonization, a catalogue with the exact name
of the variables, a description of each variable, the units, an example of
their value as well as a column for comments was prepared following
the FAIR (Findable, Accessible, Interoperable, and Re-usable) principles
(36). The harmonized datasets were uploaded by the study partners
on local servers together with their data dictionary. The following
harmonized variables were requested: age (y), sex, height (cm), weight
(kg), smoking status (never, former, and current), HDL cholesterol
(mg/dL), LDL cholesterol (mg/dL), TC (mg/dL), alcohol consumption
(g/d), total energy intake (kcal/d), dietary intakes of carbohydrates (g/d),
protein (g/d), total fat (g/d), SFA (g/d), MUFA (g/d), and PUFA (g/d)
(Supplemental Table 1).
The following variables were computed after the harmonization
process: the percentage of energy available from carbohydrates,
proteins, and fats were obtained by multiplying the number of daily
grams of carbohydrate, protein, and fat (including SFA, MUFA, and
PUFA) by their energy content per gram (4.0, 4.0, and 9.0 kcal,
respectively), and divided by the total energy intake (kcal/d). Non-
HDL cholesterol was calculated as TC minus HDL cholesterol. The
HDL cholesterol/TC ratio was calculated as the percentage of HDL
cholesterol with respect to TC (2). Smoking status was recoded
into 2 categories (never/former and current), a categorical variable
“nondrinkers and drinkers” (nondrinkers if alcohol consumption
<0.3 g/d) was created, and BMI (kg/m2) was calculated from weight
(kg) and height (in meters).
Statistical analysis
Across the 8 studies (total n = 12,983 participants), we only included
participants with complete data on HDL cholesterol and total energy
intake in the analyses (total n = 5960, 45.9%). We further excluded
participants with missing values in the outcome variable non-HDL
cholesterol (n = 1 in GINIplus/LISA, n = 1 in NESCaV) or in the
macronutrient intake variables (n = 38 in NESCaV, n = 1 for type of fats
in Pizarra), resulting in a total of 5919 individuals. Statistical analyses
were performed using the DataSHIELD tool, which allowed remote
federated analysis of harmonized datasets across the studies without
physically sharing their individual-level data (19). Briefly, individual
participant data from contributing studies were held securely on servers
at each study location (data computers [DC]) (19). A computer within
the network (analysis computer [AC]) sent analytical commands that
requested each local server (DC) to undertake an analysis locally and to
return nonidentifiable summary statistics (e.g. estimates and CIs) for
each individual study. Participants’ characteristics were described by
means (SD) for (approximately) normally distributed and medians (25–
75th percentile) for skewed distributed continuous variables, or counts
(%) for categorical variables. As statistical normality tests were not
available in DataSHIELD, normality was assessed by visual inspection
of histograms. Generalized linear regression models (GLM) were carried
out to determine the cross-sectional associations between macronutrient
composition (independent variables) and HDL cholesterol and non-
HDL cholesterol concentrations, as well as the HDL cholesterol/TC
ratio (dependent variables). DataSHIELD offers 2 complementary
approaches: 1) a full-likelihood-based individual person data (IPD)
methodology (also known as the “virtual IPD analysis”) where data
are effectively analyzed on an individual person basis, but without
physically moving them from their usual trusted repository. This
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approach generates the same results as if the data from all sources
were physically transferred to a central warehouse and analyzed jointly
(19). 2) A study level meta-analysis (SLMA), sometimes called federated
meta-analysis, where the analysis is undertaken in each study separately
and then all the resultant estimates and SEs are combined using
conventional SLMA methods.
We conducted virtual IPD GLM as a primary analysis approach. In
order to compare the results, we conducted SLMA GLM as secondary
analysis. For the virtual IPD analysis, each GLM was fitted in a federated
manner using the iterative reweighted least squares process. At each
iteration, DataSHIELD transmitted the score vectors and information
matrices – which are fully efficient nondisclosive summary statistics –
from each study to the AC (37). For the SLMA, GLMs were fitted to
completion in each study and DataSHIELD then transmitted the study-
specific effect estimates and SEs – again, nondisclosive – to the AC
(19), where they were combined across studies using random-effects
meta-analysis under restricted maximum likelihood (REML) using R
“metafor” packages v. 3.3.2. Heterogeneity was tested using chi2 and
I2 statistics (38). Significance was set as P <0.05 for the chi2 test.
Careful interpretation of the value of I2 depends on the magnitude
and direction of effects, and strength of evidence for heterogeneity. I2
values of 0–40%, 30–60%, 50–90%, and 75–100% were considered
to indicate low, moderate, substantial, and considerable heterogeneity,
respectively.
Multivariable nutrient density models were used to estimate the
association of isocaloric replacement (as 5% of energy) of carbohydrate
with total fats or with different types of fats namely SFA, MUFA,
and PUFA. The 5% increment was chosen to be comparable to
previous investigations on macronutrient composition (12). Percentages
of energy from total fat or different types of fats (SFA, MUFA, and
PUFA) were included as exposure variables along with percentage
of energy from proteins and total energy intake as covariates (39).
The coefficients of these multivariable nutrient density models indicate
differences in blood lipid concentrations associated with replacing 5%
of energy intake from carbohydrates with equivalent energetic amounts
of dietary fats.
The adjustment variables were chosen a priori and were comparable
to the set of covariates used in similar analyses on macronutrient
intake and lipoprotein profiles described elsewhere (40, 41). Missing
values for smoking status were found in BVS II (n = 1), INGI-FVG
(n = 14), DONALD (n = 50), GINIplus and LISA (n = 69), and
NESCaV (n = 2) studies. In addition, missing values for BMI were
found in INGI-FVG (n = 62), GINIplus and LISA (n = 11), and
NESCaV (n = 1) studies. Missing data were handled separately for
each study by simple imputations. Briefly, missing data for smoking
status were handled by imputing the missing values with the value
for the most frequent category among the total study population
since no sex-specific differences were observed, and missing data for
BMI was handled by imputing missing values with sex-specific median
values. Regression models were computed separately for each blood
lipid and macronutrient association. We constructed 2 models with
different adjustments for covariates. Model 1 included percentage
of energy from proteins (continuously), total energy intake (kcal/d),
alcohol consumption (nondrinker [yes/no] and continuous intake
in g/d), and study source. Model 2 was further adjusted for age
(y), sex, smoking status (never/former, current), and BMI. Analyses
were conducted in males and females combined as well as stratified
by sex.
We assessed linear regression assumptions through histograms
and scatter plots of regression residuals and fitted values using
privacy-preserving variants of standard regression diagnostics recently
implemented in DataSHIELD (42). We also investigated the potential
for collinearity between model terms. In addition, in order to investigate
whether potentially nonlinear associations exist we added quadratic
terms of percentage of energy from total fat, SFA, MUFA, and PUFA
separately to the models along with the linear terms and checked their
significance using the Wald test.
In order to examine whether observations were consistent across
different age groups, we also conducted stratified analyses by age (≤30
[n = 6 studies], 31–40 [n = 4], 41–50 [n = 4], 51–60 [n = 5] and >60 y
[n = 5]). All participants from GINIplus and LISA fell into the age
category ≤30 y. Participants from the DONALD study fell into the
first 2 categories (≤30 and 31–40 y). However, aggregated results
for the age category of 31–40 y were not returned by DataSHIELD
because they were disclosive. A contingency table is considered as
providing a potential disclosure risk, if any of its cells have less counts
than a prespecified threshold (43). To address this problem under
DataSHIELD, each DC tested any contingency table that was created
and only returned a full table to the AC if all cells were empty
or contained ≥5 observations. The EPIC substudy had participants
in the last 3 age categories (41–50, 51–60, and >60 y); however,
aggregated results for the age category of 41–50 y could not be used
since they were potentially disclosive. ActivE was removed from the
age-stratified analyses due to disclosive results in all age categories.
Statistical interactions were investigated in GLM virtual IPD analyses
by including a crossproduct term for macronutrient intake, e.g. total
fats or type of fats (continuous), and the stratification variable (age
[continuous] or sex), along with the main effect terms of each in the
model with each blood lipid as the dependent variable. All studies were
included in the interaction analysis. The P value for interaction was
determined by a Wald test.
Results were considered statistically significant at a level of P <0.05
throughout. All statistical analyses were performed in DataSHIELD
version 5.0.0 (19).
Results
The number of included participants with complete data from
the 8 studies ranged between 50 and 2126, totaling 5919
participants’ data available for a combined analysis, of which
3197 (54%) were female (Table 2). The percentage of female sex
ranged between 49% (EPIC substudy) to 65% (Pizarra). Mean
HDL cholesterol concentrations ranged between 46.6 mg/dL
(BVS II) and 67.1 mg/dL (Pizarra). Mean non-HDL cholesterol
concentrations ranged between 108 mg/dL (DONALD study)
and 184 mg/dL (Pizarra). Median intakes of total fats ranged
from 30.6% (GINIplus and LISA) to 42.6% (Pizarra), SFA
ranged from 9.13% (INGI-FVG) to 16.7% (EPIC substudy),
MUFA ranged from 10.9% (GINIplus and LISA) to 18.9%
(Pizarra), and PUFA ranged from 2.98% (INGI-FVG) to 6.63%
(EPIC substudy).
We assessed linear regression assumptions and no violations
were observed. Furthermore, little or no multicollinearity was
observed in the data (data not shown). The associations between
(5% of energy) replacement of carbohydrates with total and
different types of fats and HDL cholesterol and non-HDL
cholesterol are depicted in Table 3 and stratified by sex in
Table 4. In the fully adjusted model including sex, age, smoking
status, and BMI (model 2) replacing 5% of energy from
carbohydrates with the same amount of energy from total
fat was statistically significantly associated with 0.67 mg/dL
(95% CI: 0.40, 0.94; P <0.0001) higher HDL cholesterol. No
statistically significant associations between the replacement
of carbohydrates with total fats and non-HDL cholesterol
concentrations were observed (–0.37 mg/dL, 95% CI: –1.10,
0.36; P = 0.32) (Table 3). Although the isocaloric replacement
of carbohydrates with SFAs was not associated with higher
HDL cholesterol, it was statistically significantly associated with
1.94 mg/dL (95% CI: 0.08, 3.79; P = 0.04) higher non-HDL
cholesterol in model 2. The higher intake of MUFAs in place
of carbohydrates was statistically significantly associated with
0.99 mg/dL (95% CI: 0.37, 1.60; P = 0.002) higher HDL
cholesterol, but no associations were found with non-HDL
cholesterol concentrations. A higher PUFA intake in place of
carbohydrates yielded no statistically significant associations
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TABLE 3 Associations between replacement of 5% of energy from carbohydrates with total fats
or types of fats and HDL cholesterol and non-HDL cholesterol among adolescents and adults from
8 European studies (n = 5919)1
HDL-C Non-HDL-C
Type of fat β (95% CI) P value β (95% CI) P value
Total fats
Model 1 0.81 (0.52, 1.09)∗ <0.0001 –0.12 (–0.86, 0.63) 0.76
Model 2 0.67 (0.40, 0.94)∗ <0.0001 –0.37 (–1.10, 0.36) 0.32
SFA
Model 1 1.37 (0.64, 2.10)∗ 0.0002 2.20 (0.31, 4.09)∗ 0.02
Model 2 0.55 (–0.13, 1.23) 0.11 1.94 (0.08, 3.79)∗ 0.04
MUFA
Model 1 0.46 (–0.20, 1.12) 0.17 –0.77 (–2.47, 0.93) 0.37
Model 2 0.99 (0.37, 1.60)∗ 0.002 –0.85 (–2.51, 0.81) 0.32
PUFA
Model 1 0.12 (–1.09, 1.33) 0.85 –2.80 (–5.94, 0.34) 0.08
Model 2 –0.30 (–1.43, 0.83) 0.61 –3.91 (–6.98, –0.84)∗ 0.01
1Data are β-coefficients, upper and lower 95% CIs for all participants. Values of HDL cholesterol and non-HDL cholesterol are
expressed in mg/dL and total fat, SFA, MUFA, and PUFA intakes as 5% energy. General linear regression models were used.
Model 1 was adjusted for alcohol (yes, no, and continuously in g/d), protein intake, 5% energy (continuously), total energy intake
(kcal/d), and study source (EPIC substudy, ActivE, BVS II, DONALD, Pizarra, NESCaV, GINIplus and LISA, INGI-FVG); and model 2
was additionally adjusted for age (y), sex, smoking status (never/former, current), and BMI (kg/m2). ∗P < 0.05. BVS II, Bavarian Food
Consumption Survey II; DONALD, DOrtmund Nutritional and Anthropometric Longitudinally Designed Study; EPIC, European
Prospective Investigation into Cancer and Nutrition; GINIplus, German Infant Study on the Influence of Nutrition Intervention plus
environmental and genetic influences on allergy development; INGI-FVG, Italian Network of Genetic Isolates-Friuli Venezia Giulia;
LISA, Influence of Life-style related factors on the development of the Immune System and Allergies in East and West Germany;
GINIplus and LISA are 2 German birth cohorts whose harmonized data were pooled to increase statistical power; NESCaV,
Nutrition, Environment, and Cardiovascular Health.
with HDL cholesterol, but a statistically significant association
with lower (–3.91 mg/dL, 95% CI: –6.98, –0.84; P = 0.01)
non-HDL cholesterol concentrations (Table 3). Overall, the
models followed a linear trend, with no indication of nonlinear
associations (data not shown).
Replacing 5% of energy from carbohydrates with the same
amount of energy from total fats was more strongly associ-
ated with higher HDL cholesterol concentrations in females
(0.84 mg/dL, 95% CI: 0.46, 1.21) than in males (0.44 mg/dL,
95% CI: 0.07, 0.82; P-interaction = 0.05) (Table 4). No
statistically significant associations between the replacement of
carbohydrates with total fats and non-HDL cholesterol concen-
trations were observed either in males or females, although there
was an indication for a statistically significant interaction by sex
(P-interaction = 0.01). A statistically significant interaction by
sex was observed for the association of replacing carbohydrates
with MUFAs and non-HDL cholesterol, such that a statistically
significant inverse association was found in males and no
significant association in females (P-interaction = 0.002). No
other statistically significant interactions by sex were observed.
Findings for HDL cholesterol were comparable with the
HDL/TC ratio where HDL cholesterol was expressed as a
percentage of TC (Supplemental Table 2 and Supplemental
Figure 1).
SLMAs yielded similar results as in the virtual IPD
DataSHIELD analyses (Figure 1 and Supplemental Figures 1–
4 and Supplemental Table 3). For example, replacing 5% of
energy from carbohydrates with total fats in model 2 was
statistically significantly associated with 0.63 mg/dL (95% CI:
0.35, 0.90; P value for heterogeneity = 0.26) higher HDL
cholesterol in the SLMA, and 0.67 mg/dL (95% CI: 0.40, 0.94)
higher HDL cholesterol in the virtual IPD analysis. Substantial
heterogeneity was observed in the fully adjusted model for the
replacement of 5% of energy from carbohydrates with SFAs and
HDL cholesterol in males (I2 = 66.7%, P <0.01) and non-HDL
cholesterol in females (I2 = 54.2%, P = 0.04) (Supplemental
Table 3).
Figure 2 shows associations between the (5% of energy)
replacement of carbohydrates with total fats and different
types of fats and HDL cholesterol and non-HDL cholesterol
stratified by age groups. Positive associations between replacing
carbohydrates with total fats and HDL cholesterol concentra-
tions were most pronounced in the middle age groups, e.g.
between 41 and 50 y (1.23 mg/dL per 5% energy, 95% CI:
0.50, 1.97), as well as between 51 and 60 y (0.94 mg/dL
per 5% energy, 95% CI: 0.13, 1.75). Positive associations
between the replacement of carbohydrates with SFA and
non-HDL cholesterol concentrations were most pronounced
between 41 and 50 y (10.01 mg/dL per 5% energy, 95%
CI: 3.91, 16.11). No statistically significant interactions of
the different types of fat with age on either HDL cholesterol
or non-HDL cholesterol concentrations were observed (all
P values for interaction >0.05). Age-stratified findings for
the HDL cholesterol/TC ratio were comparable to those for
HDL cholesterol (Supplemental Table 4). The corresponding
SLMAs for HDL cholesterol, non-HDL cholesterol, and HDL
cholesterol/TC ratio showed similar findings in the age-stratified
analysis (Supplemental Table 5). Substantial heterogeneity
was observed for the associations between the replacement
of carbohydrates with MUFA (I2 = 62.8%, P = 0.03)
and PUFA (I2 = 63.3%, P = 0.04), and HDL cholesterol
concentrations in the age groups ≥60 y and 41–50 y,
respectively. Substantial heterogeneity was also observed for
the associations between the replacement of carbohydrates
with total fats (I2 = 69.9%, P = 0.02), MUFA (I2 = 74.8%,
P <0.01), and PUFA (I2 = 68.8%, P = 0.02) and non-HDL
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TABLE 4 Sex-stratified associations between replacement of 5% of energy from carbohydrates
with total fats or types of fats and HDL cholesterol and non-HDL cholesterol among adolescents and
adults from 8 European studies1
HDL-C Non-HDL-C
Type of fat β (95% CI) P value β (95% CI) P value
Total fats
Males2 (n = 2697) 0.44 (0.07, 0.82)∗ 0.02 –0.27 (–1.40, 0.85) 0.63
Females (n = 3197) 0.84 (0.46, 1.21)∗ <0.0001 –0.12 (–1.08, 0.83) 0.80
P-interaction by sex 0.05 0.01
SFA
Males2 (n = 2697) 0.68 (–0.30, 1.66) 0.18 3.73 (0.83, 6.63)∗ 0.01
Females (n = 3197) 0.43 (–0.51, 1.37) 0.37 0.63 (–1.77, 3.02) 0.61
P-interaction by sex 0.59 0.06
MUFA
Males2 (n = 2697) 0.67 (–0.25, 1.59) 0.16 –3.03 (–5.76, –0.30)∗ 0.03
Females (n = 3197) 1.16 (0.34, 1.98)∗ 0.006 0.84 (–1.24, 2.92) 0.43
P-interaction by sex 0.16 0.002
PUFA
Males2 (n = 2697) –0.49 (–2.17, 1.18) 0.56 –2.11 (–7.09, 2.87) 0.41
Females (n = 3197) –0.02 (–1.54, 1.52) 0.43 –4.08 (–7.95, –0.21)∗ 0.04
P-interaction by sex 0.21 0.38
1Data are β-coefficients, upper and lower 95% CIs. Values of HDL cholesterol and non-HDL cholesterol are expressed in mg/dL and
total fat, SFA, MUFA, and PUFA intakes as 5% energy. General linear regression models were used. Model 2 was adjusted for
alcohol (yes, no, and continuously in g/d), protein intake, 5% energy (continuously), total energy intake (kcal/d), for age (y), sex,
smoking status (never/former, current), BMI (kg/m2), and study source (EPIC substudy, ActivE, BVS II, DONALD, Pizarra, NESCaV,
GINIplus and LISA, INGI-FVG). ∗P < 0.05. BVS II, Bavarian Food Consumption Survey II; DONALD, DOrtmund Nutritional and
Anthropometric Longitudinally Designed Study; EPIC, European Prospective Investigation into Cancer and Nutrition; GINIplus,
German Infant Study on the Influence of Nutrition Intervention plus environmental and genetic influences on allergy development;
INGI-FVG, Italian Network of Genetic Isolates-Friuli Venezia Giulia; LISA, Influence of Life-style related factors on the development
of the Immune System and Allergies in East and West Germany; GINIplus and LISA are 2 German birth cohorts whose harmonized
data were pooled to increase statistical power; NESCaV, Nutrition, Environment, and Cardiovascular Health.
2ActivE study excluded in all datasets for males.
cholesterol concentrations in the age group between 31 and
40 y (Supplemental Table 5).
Discussion
In this large federated cross-sectional analysis of 8 observa-
tional studies, we found that the isocaloric replacement of
carbohydrates with total fats or MUFAs was positively
associated with HDL cholesterol, whereas the replacement
of carbohydrates with SFAs was positively associated with
non-HDL cholesterol concentrations. The replacement of
carbohydrates with PUFAs was inversely associated with non-
HDL cholesterol concentrations. Although most associations
were similar and in the same direction in males and females,
the replacement of carbohydrates with MUFAs was inversely
associated with non-HDL cholesterol in males but not in
females. We observed no statistically significant interaction by
age, although estimates varied across age groups.
In agreement with our findings, there is convincing evidence
from randomized trials that the replacement of carbohydrates
with total fat or MUFAs increases HDL cholesterol in
adults (15, 16, 44, 45). For example, a meta-analysis of
395 published dietary intervention studies conducted under
controlled conditions with diets persisting ≥2 wk (so-called
metabolic ward studies) found that isocaloric increases in
MUFA (replacing carbohydrates) increased HDL cholesterol
concentrations (45).
It is well-known that a higher intake of SFAs increases LDL
cholesterol concentrations, which is considered a major risk
factor for CVDs (46, 47). The replacement of carbohydrates
with SFAs has been consistently associated with higher LDL
cholesterol in randomized trials (15, 16, 48) but not in
observational studies (26). However, to our knowledge, no
intervention or observational studies relating the isocaloric re-
placement of carbohydrates with SFAs to non-HDL cholesterol
concentrations are currently available.
Literature addressing non-HDL cholesterol in the context
of replacing dietary carbohydrates with PUFAs or MUFAs
is scarce, whereas results on LDL cholesterol from existing
intervention (14–16, 45) and observational studies (26) are con-
flicting. For example, a randomized, 3-period, crossover feeding
study observed that the partial substitution of carbohydrates
with unsaturated fats (mainly MUFAs) showed no effects on
LDL cholesterol concentrations (14), whereas a meta-analysis
of 27 trials (16) and a large systematic review of 84 trials (15)
showed that the isocaloric substitution of total carbohydrates
with MUFAs or PUFAs significantly decreased LDL cholesterol
concentrations. In addition, a meta-analysis of 395 published
metabolic ward studies found that isocaloric increases in PUFA
intake (replacing carbohydrates) decreased LDL cholesterol,
whereas MUFAs had no significant effect on LDL cholesterol
(45). Differences in results may be partly explained by study-
specific differences in the n–6/n–3 PUFA ratio, since n–6 versus
n–3 PUFAs may exert differential effects on lipid profiles (26,
46).
Isocaloric macronutrient exchange models should be inter-
preted cautiously, as any observed association may be attributed
to either the macronutrient of interest (in our case, types of fat)
or to the substituted macronutrient. Similar to other studies
(12), we chose carbohydrates as a reference macronutrient
for our isocaloric exchange models. We conducted additional
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FIGURE 1 Forest plot of random-effects study-level meta-analysis for the association between lipoprotein profiles and percentage of 5% of
energy intake from total fats in replacement of carbohydrates among adolescents and adults from 8 European studies. Values are β-coefficients,
upper and lower 95% CIs for all the participants (n = 5919). HDL cholesterol and non-HDL cholesterol were expressed in mg/dL and total fat intake
was expressed as 5% energy. Model 2 was adjusted for alcohol (yes, no, and continuously in g/d), protein intake, 5% energy (continuously), total
energy intake (kcal/d), for age (y), sex, smoking status (never/former, current), BMI (kg/m2), and study source. The shaded circles represent the
point estimate for each individual study, and the horizontal line extending from each square represents the upper and lower limits of the 95% CI.
The size of the shaded square indicates the relative weight of the study in the meta-analysis. The diamonds represent the overall β-coefficient of
the studies. BVS II, Bavarian Food Consumption Survey II; DONALD, DOrtmund Nutritional and Anthropometric Longitudinally Designed Study;
EPIC, European Prospective Investigation into Cancer and Nutrition; GINI, German Infant Study on the Influence of Nutrition Intervention; INGI-
FVG, Italian Network of Genetic Isolates-Friuli Venezia Giulia; IV, interval variable; LISA, Influence of Life-style related factors on the development
of the Immune System and Allergies in East and West Germany; GINIplus and LISA are 2 German birth cohorts whose harmonized data were
pooled to increase statistical power; NESCaV, Nutrition, Environment, and Cardiovascular Health; TE, estimated treatment effect.
substitution models in which fats were replaced at the expense
of protein intake (instead of carbohydrates) and similar results
were found, further supporting that our observations can largely
be attributed to fat intake. Most studies in the present analysis
had median carbohydrate intakes <50%, which is lower
than the recommended intake by many European nutrition
societies (49–52). To avoid unhealthy weight gain, the German
guidelines (49) recommend limiting total fat intake to <30%
of total energy intake (from age 15 y, 30–35% between 4
and 15 y), whilst the Belgian (51), Spanish (52), and Italian
(53) guidelines recommend limiting total fat intake ≤35% of
total energy intake. However, there is an ongoing debate on
limiting the intake of total fats to <30% of the total energy
intake as previous studies suggest that diets with a higher
fat intake are not associated with higher CVD or mortality
risk(40). In addition, in terms of unhealthy weight gain, total
calorie intake rather than macronutrient composition is the
determinant, which underlines the special importance of the
isocaloric replacement of macronutrients.
A number of experimental studies in animal models aimed
to elucidate the mechanisms by which different types of fatty
acids modulate circulating cholesterol concentrations (54–59).
Resultant plausible mechanisms that could explain how dietary
fats affect circulating LDL cholesterol concentrations include
alterations in LDL cholesterol receptor activity, LDL cholesterol
receptor protein concentrations, and mRNA abundance (55–
58); whilst SFAs markedly decrease the LDL cholesterol recep-
tor activity and protein and mRNA concentrations (59), PUFAs
upregulated them (55). Furthermore, (n–6) PUFA reduces
circulating cholesterol by upregulating the LDL cholesterol re-
ceptor and increasing the activity of cholesterol 7α-hydroxylase
(CYP7) – the initial and rate-limiting enzyme in the conversion
of cholesterol to bile acids (60). In human studies, key
components of cholesterol metabolism are the cholesterol efflux
(a measure of HDL cholesterol functionality), and proprotein
convertase subtilisin-kexin type 9 (PCSK9) concentrations,
a protein involved in the degradation of LDL cholesterol
receptors (60). A randomized trial has shown that a higher
intake of PUFAs reduces PCSK9 concentrations (61), which
could be another mechanism that might explain why PUFAs
exert lipoprotein benefits. However, to our knowledge there
are no experimental studies examining specifically biological
mechanisms for the effects of replacing carbohydrates with
types of fat on HDL or non-HDL concentrations.
A major strength of this study is that it used federated data
from large studies conducted in several European countries





























































































































































































































































FIGURE 2 Age-stratified analyses on the association between replacement of 5% of energy from carbohydrates with total fats (A and B), SFAs
(C and D), MUFAs (E and F), or PUFAs (G and H) and HDL cholesterol and non-HDL cholesterol among adolescents and adults from 8 European
studies. Values are β-coefficients, upper and lower 95% CIs for all the participants (n = 5919). HDL cholesterol and non-HDL cholesterol were
expressed in mg/dL and total fat, SFA, MUFA, and PUFA intakes were expressed as 5% energy. The circles represent the point estimate for
each age group, and the horizontal line extending from each circle represents the upper and lower limits of the 95% CI. Model 2 was adjusted
for alcohol (yes, no, and continuously in g/d), protein intake, 5% energy (continuously), total energy intake (kcal/d), for age (y), sex, smoking
status (never/former, current), BMI (kg/m2), and study source. Included studies for age category ≤30 y (BVS II, Pizarra, NESCaV, INGI-FVG,
GINIplus/LISA, and DONALD); 31–40 and 41–50 years (BVS II, Pizarra, INGI-FVG, and NESCaV); 51–60 and >60 y (BVS II, EPIC substudy, Pizarra,
INGI-FVG, and NESCaV); age categories: ≤30 y (n = 2758); 31–40 y (n = 561); 41–50 y (n = 603); 51–60 y (n = 761), and >60 y (n = 1,141). No
significant interactions between fats and age were found. BVS II, Bavarian Food Consumption Survey II; DONALD, DOrtmund Nutritional and
Anthropometric Longitudinally Designed Study; EPIC, European Prospective Investigation into Cancer and Nutrition; GINIplus, German Infant
Study on the Influence of Nutrition Intervention plus environmental and genetic influences on allergy development; INGI-FVG, Italian Network
of Genetic Isolates-Friuli Venezia Giulia; LISA, Influence of Life-style related factors on the development of the Immune System and Allergies
in East and West Germany; GINIplus and LISA are 2 German birth cohorts whose harmonized data were pooled to increase statistical power;
NESCaV, Nutrition, Environment, and Cardiovascular Health.
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covering the South and Central Europe, as well as including
broad age ranges, showing consistent results across the diverse
studies. Another strength is that a priori FAIRyfied harmo-
nization of data before individual-level and study-level meta-
analyses were carried out. In addition, the remote federated
analysis approach through DataSHIELD allowed us to perform
both virtual IPD and study-level meta-analyses without the
need to physically pool or share individual-level data, and
hence substantially reduced the governance burdens and
ethicolegal challenges. Similar effect estimates were observed
between the virtually pooled analysis of individual-level data
and study-level meta-analyses; the latter though provided, as
expected, larger CIs, sometimes losing the statistical significance
observed in the virtual IPD analyses. However, by using both
virtual IPD GLM analyses and study-level meta-analyses, we
demonstrated that there are no serious flaws in the analytic
assumption that could disturb either approach: in particular,
no serious heterogeneity in the underlying etiological models.
The implementation of DataSHIELD in DASH-IN made it
possible to perform individual-level analysis. Collection of data
via this type of solution may stimulate research on existing
data.
Our study has several limitations. First, given the cross-
sectional nature of our analyses, we can neither confirm the
temporal relation between the substitution of carbohydrates for
fats and the lipoprotein profiles in our study population nor
infer causality. Second, we included 8 studies from 4 European
countries among the observational studies identified within the
ENPADASI Consortium. Therefore, although participants were
recruited from the general population, our studies may not
be representative of the European population. Third, residual
confounding cannot be ruled out, since not all the studies had
potentially important confounding variables such as education,
physical activity, and waist circumference available. Fourth,
small studies had to be left out in stratified analysis by age
and sex due to the risk of potentially disclosive results, which
lowered statistical power and hence reduced the chance of
detecting a true effect. Fifth, an increased risk of making a
Type I error could not be ruled out, especially since we tested
multiple outcomes in our exploratory analysis. However, we did
not find substantial differences with the level of significance
after applying a conservative Bonferroni correction for 12
independent tests (3 outcomes, 4 exposures) although the as-
sociations between the isocaloric replacement of carbohydrates
with SFA or PUFA with higher and lower non-HDL cholesterol
concentrations, respectively, were no longer significant after
Bonferroni correction for 12 tests (P value >0.004). Sixth,
it is known that the effects of replacing carbohydrates may
depend in part on the quality of the carbohydrates, however,
the quality of carbohydrates was not taken into account, e.g.
by considering glycemic index (41, 47). In addition, we did
not assess differences in the n–6/n–3 PUFA ratio or differences
in the food sources of the considered nutrients, e.g. animal-
derived MUFA versus plant-derived MUFA, which may have
exerted differential effects on lipid profiles. Seventh, random
measurement error cannot be ruled out from having diluted real
associations between nutrients and lipoprotein profiles. One
potential source of random measurement error may reside in
the methods used for the assessment of dietary macronutrients
intake, which was obtained from self-reported FFQs, food
records, or 24-h recall as well as the methods and medium used
to measure lipoproteins (plasma, which was used in the EPIC
substudy versus serum, which was used in all other studies).
However, from the forest plots we did not observe substantial
heterogeneity among studies for most associations (substantial
heterogeneity was only observed in a few associations after
stratification by sex or age), meaning that we largely did not
find differences between studies with different dietary collection
methods, lipoprotein measurement methods, nor studies using
plasma versus serum as an analysis medium nor differences
between studies located in the South or Central Europe. Whilst
it is true that center-specific effects could not be fully elucidated,
we adjusted for study source, which partly accounted for
center-specific effects. Eighth, data on smoking and BMI were
missing for only a few participants. However, we used simple
imputations for missing values in 2 covariables, namely BMI
and smoking status, to minimize the loss of statistical power,
since multiple imputation was not yet available in DataSHIELD
version 5.0.0 and the relative simplicity of the underlying data
structure was such that the approach to simple imputation was
intuitive.
In conclusion, the findings from this large cross-sectional
federated analysis of 8 European observational studies suggest
that in adolescents and adults, replacing dietary carbohydrates
with total fats and MUFAs is related to higher HDL cholesterol
concentrations. Our findings also suggest that replacing dietary
carbohydrates with either MUFAs or PUFAs is related to lower
non-HDL cholesterol, whereas replacing dietary carbohydrates
with SFAs is associated with higher non-HDL cholesterol
concentrations. The findings on non-HDL cholesterol warrant
confirmation by future studies. The consumption of fats in
place of carbohydrates showed beneficial effects when fats were
consumed in the form of MUFAs or PUFAs but not SFAs. Thus,
our findings support global dietary guidelines (62) regarding
the detrimental effects of saturated fat intake, although – as
has also been indicated in previous studies (40, 63, 64) –
the intake of total fats showed no detrimental effects in the
blood lipoprotein profiles. Federated analysis on data is possible
and can answer research questions without sharing individual
data.
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